Tim Goodship

4.5k total citations
47 papers, 2.2k citations indexed

About

Tim Goodship is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Tim Goodship has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 19 papers in Nephrology and 16 papers in Hematology. Recurrent topics in Tim Goodship's work include Complement system in diseases (32 papers), Renal Diseases and Glomerulopathies (13 papers) and Blood groups and transfusion (12 papers). Tim Goodship is often cited by papers focused on Complement system in diseases (32 papers), Renal Diseases and Glomerulopathies (13 papers) and Blood groups and transfusion (12 papers). Tim Goodship collaborates with scholars based in United Kingdom, United States and France. Tim Goodship's co-authors include David Kavanagh, Anna Richards, Marie Scully, Véronique Frémeaux‐Bacchi, C. Mark Taylor, Stephen J. Wigmore, Sam Machin, Lisa Strain, Christine Skerka and Peter F. Zipfel and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PEDIATRICS.

In The Last Decade

Tim Goodship

46 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tim Goodship 1.7k 1.2k 647 297 296 47 2.2k
Carla Nester 2.5k 1.4× 2.0k 1.7× 948 1.5× 251 0.8× 471 1.6× 85 3.1k
Agnès Veyradier 2.4k 1.4× 1.3k 1.1× 1.8k 2.8× 71 0.2× 962 3.3× 108 3.3k
Katerina Pavenski 1.0k 0.6× 493 0.4× 970 1.5× 52 0.2× 421 1.4× 103 2.2k
Karim Kentouche 1.0k 0.6× 439 0.4× 801 1.2× 40 0.1× 293 1.0× 59 1.8k
Flore Sicre de Fontbrune 861 0.5× 404 0.3× 837 1.3× 137 0.5× 426 1.4× 107 1.9k
Michel Delahousse 1.1k 0.7× 1.3k 1.1× 255 0.4× 87 0.3× 128 0.4× 65 3.3k
Sylvia Benjamin 1.2k 0.7× 686 0.6× 766 1.2× 41 0.1× 421 1.4× 20 1.6k
Véronique Baudouin 467 0.3× 994 0.8× 317 0.5× 29 0.1× 289 1.0× 84 1.9k
Kenneth D. Friedman 894 0.5× 379 0.3× 2.0k 3.1× 33 0.1× 514 1.7× 98 3.0k
Jean‐Claude Davin 670 0.4× 889 0.7× 210 0.3× 101 0.3× 137 0.5× 35 1.4k

Countries citing papers authored by Tim Goodship

Since Specialization
Citations

This map shows the geographic impact of Tim Goodship's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Goodship with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Goodship more than expected).

Fields of papers citing papers by Tim Goodship

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Goodship. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Goodship. The network helps show where Tim Goodship may publish in the future.

Co-authorship network of co-authors of Tim Goodship

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Goodship. A scholar is included among the top collaborators of Tim Goodship based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Goodship. Tim Goodship is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Mark R., Rajkumar Chinnadurai, Ashish Sharma, et al.. (2016). Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.. American Journal of Transplantation.
2.
Zipfel, Peter F., Christine Skerka, Qian Chen, et al.. (2015). The role of complement in C3 glomerulopathy. Molecular Immunology. 67(1). 21–30. 72 indexed citations
3.
Wood, Katrina, et al.. (2015). Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab. Transplantation Proceedings. 47(7). 2258–2261. 6 indexed citations
4.
Phillips, Elizabeth H., John‐Paul Westwood, Vicky Brocklebank, et al.. (2015). The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies. Journal of Thrombosis and Haemostasis. 14(1). 175–185. 34 indexed citations
5.
Sofat, Reecha, P. Patrizia Mangione, J. Ruth Gallimore, et al.. (2013). Distribution and determinants of circulating complement factor H concentration determined by a high-throughput immunonephelometric assay. Journal of Immunological Methods. 390(1-2). 63–73. 30 indexed citations
6.
Wong, Edwin, Tim Goodship, & David Kavanagh. (2013). Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Molecular Immunology. 56(3). 199–212. 62 indexed citations
7.
Kavanagh, David, Anna Richards, Tim Goodship, & Hannu Jalanko. (2010). Transplantation in Atypical Hemolytic Uremic Syndrome. Seminars in Thrombosis and Hemostasis. 36(6). 653–659. 43 indexed citations
8.
Sayer, John A., et al.. (2010). Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation. QJM. 104(10). 881–883. 5 indexed citations
9.
Johnson, Sally, Anna Richards, Stephen J. Perkins, et al.. (2010). Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome—A pedigree revisited. Molecular Immunology. 47(7-8). 1585–1591. 8 indexed citations
10.
Kavanagh, David & Tim Goodship. (2010). Genetics and complement in atypical HUS. Pediatric Nephrology. 25(12). 2431–2442. 111 indexed citations
11.
Davin, Jean‐Claude, Valentina Gracchi, Antonia H. Bouts, et al.. (2009). Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation. American Journal of Kidney Diseases. 55(4). 708–711. 84 indexed citations
12.
Reed, Adam J., Juris Galvanovskis, Corinne Antignac, et al.. (2009). Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. Human Molecular Genetics. 18(16). 2963–2974. 80 indexed citations
13.
Waters, Aoife, Isabel Y. Pappworth, Kevin J. Marchbank, et al.. (2009). Successful Renal Transplantation in Factor H Autoantibody Associated HUS with CFHR1 and 3 Deficiency and CFH Variant G2850T. American Journal of Transplantation. 10(1). 168–172. 31 indexed citations
14.
Taylor, C. Mark, Sam Machin, Stephen J. Wigmore, & Tim Goodship. (2009). Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom. British Journal of Haematology. 148(1). 37–47. 150 indexed citations
15.
Davin, Jean‐Claude, et al.. (2009). Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome. Pediatric Nephrology. 24(9). 1757–1760. 28 indexed citations
16.
Davin, Jean Claude, Lisa Strain, & Tim Goodship. (2008). Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatric Nephrology. 23(9). 1517–1521. 36 indexed citations
17.
18.
Min, Sangil, Peter Rutherford, Mairi Ward, et al.. (1996). Goodpasture's syndrome with normal renal function. Nephrology Dialysis Transplantation. 11(11). 2302–2305. 15 indexed citations
19.
Thomson, A. G., et al.. (1995). The effect of dietary intervention on the management of hyperlipidemia in British renal transplant patients. Journal of Renal Nutrition. 5(2). 73–77. 9 indexed citations
20.
Goodship, Tim, et al.. (1986). Acute renal failure associated with acute pyelonephritis and consumption of non-steroidal anti-inflammatory drugs.. BMJ. 292(6513). 97.2–98. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Nester Breakdown of academic impact, for papers by Agnès Veyradier Breakdown of academic impact, for papers by Katerina Pavenski Breakdown of academic impact, for papers by Karim Kentouche Breakdown of academic impact, for papers by Flore Sicre de Fontbrune Breakdown of academic impact, for papers by Michel Delahousse Breakdown of academic impact, for papers by Sylvia Benjamin Breakdown of academic impact, for papers by Véronique Baudouin Breakdown of academic impact, for papers by Kenneth D. Friedman Breakdown of academic impact, for papers by Jean‐Claude Davin
Rankless by CCL
2026